article thumbnail

SS Innovations’ SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement

DAIC

a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced that surgeons have successfully performed the world’s first mitral valve replacement using the Made in India, SSi Mantra Surgical Robotic System. from 2022 to 2031.

article thumbnail

Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves

Circulation: Cardiovascular Interventions

BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Ascending aortic diameter was the single predictor of 1-year mortality in type 0 bicuspid patients (hazard ratio, 1.59 [95% CI, 1.03–2.44];P=0.035). Poverall=0.522; 1 year: 10% versus 2.3%

article thumbnail

SAVR’s Value in the TAVR Era

CardiacWire

The researchers analyzed 200k nationwide adults who underwent SAVR between 2011 and 2022, finding that… Annual SAVR volumes decreased by 45% (19,560 to 10,851). to 55% of total SAVRs), while SAVR ratios increased among patients with bicuspid aortic valves (from 15.5% to 54.5%), but declined among 65-79yr (49.2%

TAVR 69
article thumbnail

Conduction Disturbances and Outcome After Surgical Aortic Valve Replacement in Patients With Bicuspid and Tricuspid Aortic Stenosis

Circulation

BACKGROUND:This study aimed to compare the incidence and prognostic implications of new-onset conduction disturbances after surgical aortic valve replacement (SAVR) in patients with bicuspid aortic valve (BAV) aortic stenosis (AS) versus patients with tricuspid aortic valve (TAV) AS (ie, BAV-AS and TAV-AS, respectively).

article thumbnail

Echocardiographic Profiling Predicts Clinical Outcomes After Mitral Transcatheter Edge?to?Edge Repair

Journal of the American Heart Association

BackgroundPrior studies investigating the impact of residual mitral regurgitation (MR), tricuspid regurgitation (TR), and elevated predischarge transmitral mean pressure gradient (TMPG) on outcomes after mitral transcatheter edge‐to‐edge repair (TEER) have assessed each parameter in isolation. 7.33],P=0.02).ConclusionsThe

article thumbnail

BioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal Application

DAIC

Procedures that leverage transseptal delivery include atrial fibrillation ablation , patent foramen ovale (PFO) and atrial septal defect (ASD) repair, percutaneous mitral valve repair, left atrial appendage closure, and percutaneous left ventricular assist device placement, among others. billion by the end of 2033.

article thumbnail

What is new in Heart failure management ? Ultrasonic cardiac re-synchronization : The WiSE -CRT device

Dr. S. Venkatesan MD

In the process, improving the ejection fraction and possibly reducing mitral regurgitation. 2022 Jan;19(1):22-29. It works on the principle of aggregating mechanically wasted and disorganized myocardial contractile force into a coherent forward pushing activity. Heart Rhythm. doi: 10.1016/j.hrthm.2021.06.1195. 2021.06.1195.